Thermo Fisher Scientific Inc., a major global player in the life sciences sector, has announced plans to invest $2 billion in its U.S. operations over the next four years. The investment is aimed at bolstering American innovation, enhancing manufacturing capacity,
Johnson & Johnson has announced a $55 billion investment in U.S. manufacturing, research, and technology over the next four years, marking a 25% increase over the previous period. The initiative builds upon the company’s existing U.S. investment levels, which were elevated
Pfizer is prepared to adapt if pharmaceutical tariffs are introduced under a second Trump administration, CEO Albert Bourla, Ph.D., said at TD Cowen’s 45th annual healthcare conference in Boston. The company already operates 13 manufacturing sites across the U.S. and could
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups Sign up for our weekly newsletter
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
